Growth Hormone Deficiency in Children Completed Phase 4 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0034025 (Growth Hormone Deficiency in Children)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00567385Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyTreatment